US OptionsDetailed Quotes
LULU241213C330000
- 58.30
- -1.40-2.35%
15min DelayClose Dec 13 16:00 ET
59.40High57.20Low
57.20Open59.70Pre Close9 Volume212 Open Interest330.00Strike Price52.14KTurnover0.00%IV-0.85%PremiumDec 13, 2024Expiry Date61.63Intrinsic Value100Multiplier-1DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma6.35Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Lululemon Athletica Stock Discussion
Sign in to post a comment
$Esperion Therapeutics (ESPR.US)$ $Esperion Therapeutics (ESPR.US)$ Esperion Therapeutics (ESPR) is a biotech company that focuses on developing and commercializing therapies to lower cholesterol, specifically offering the only FDA-approved statin alternatives: NEXLIZET and NEXLETOL for PRIMARY PREVENTION. These drugs are designed for individuals who are statin intolerant or cannot achieve adequate cholesterol lowering with statin...
+4
1
6
$Lululemon Athletica (LULU.US)$
Ultimate Supreme Tool - Full Description
---
The Ultimate Supreme Tool is a comprehensive, all-in-one trading, analysis, and predictive intelligence platform designed to give Darren James Burton an unrivaled edge over Wall Street. This tool integrates all the features, capabilities, and enhancements of Darren’s previous tools, such as The Mad Black Woman, The Decepticon,...
Ultimate Supreme Tool - Full Description
---
The Ultimate Supreme Tool is a comprehensive, all-in-one trading, analysis, and predictive intelligence platform designed to give Darren James Burton an unrivaled edge over Wall Street. This tool integrates all the features, capabilities, and enhancements of Darren’s previous tools, such as The Mad Black Woman, The Decepticon,...
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esperion has the only FDA approved statin alternative drugs NEXLIZET & NEXLETOL for Primary Prevention, Statins are a class of prescription drugs that help lower cholesterol levels. They are the most common treatment for high cholesterol, an estimated 21 Million Americans are Statin intolerant and or maxed out on Statin drugs and need additional lowering. Over 71 ...
+2
9
1
4
![[undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36 "undefined"){kind=small}
The stock market is finally pulling back a little bit after going up for the longest time. The market was dragged down by a few big tech names, especially Nvidia, who fell 2.55% after negative news came out from China.
On a side note, bitcoin retreated as well after closing above $100K.
It’s good to see such retracement as the markets (both equities and bitcoin) have been overheated for quite a while already.
A retracement now and then a Santa rally later will be ideal for m...
On a side note, bitcoin retreated as well after closing above $100K.
It’s good to see such retracement as the markets (both equities and bitcoin) have been overheated for quite a while already.
A retracement now and then a Santa rally later will be ideal for m...
From YouTube
17
4
$Lululemon Athletica (LULU.US)$ why it dropped so much... should I still hold on?
1
5
$Lululemon Athletica (LULU.US)$ is it already lost momentum?😝
2
On last Friday (06 Dec) we saw the stocks rose after the much anticipated employment data came in largely as expected, reinforcing investor confidence in the strength of the economy and expectations that the Federal Reserve will cut interest rates again.
The S&P 500 and NASDAQ rose 0.25% and 0.81%, respectively, both hitting record closing highs, while the DJIA finished 0.28% lower after giving back earlier gai...
The S&P 500 and NASDAQ rose 0.25% and 0.81%, respectively, both hitting record closing highs, while the DJIA finished 0.28% lower after giving back earlier gai...
+3
18
No comment yet
Millaai : Are you being trapped and looking for a rescuer everywhere?
Growth Investor27 : Good info, NEXLIZET is a great drug, my brother takes it. ESPR stock is undervalued, should be above $5
Growth Investor27 Millaai : The author has been buying below $2 so your comment is off. This research article has all the due diligence to see, other than the fact Institutions have been heavly buying this year, fintel shows now 74% owned. ESPR is a good investment.
104248191 : please f o
Detached House Millaai : You are wrong. Though short term looks like the price is consolidating, the weekly chart looks promising! So look at the chart to see if it aligns with the fundamentals before criticising others!
View more comments...